2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Genomics, Genomic technology and Epigenetics<br />
sequence variation relative to a control sample; however, HRM does<br />
not impart the identity <strong>of</strong> the variation, and sequencing is required to<br />
exactly identify the nucleotide changes. Since HRM is an end-point<br />
PCR analysis technique, we further developed a workflow enabling<br />
the product <strong>of</strong> HRM PCR to be used directly in a Sanger sequencing<br />
reaction after a simple 100 to 200 fold dilution. The direct sequencing<br />
approach conserves sample by eliminating another round <strong>of</strong> PCR to<br />
generate product for sequencing. And the high ratio dilution eliminates<br />
the need for a purification step after PCR. The fluorescent dye used<br />
for HRM does not interfere with the sequencing reaction. To further<br />
simplify the workflow, universal M13 tags were added to the 5’ end<br />
<strong>of</strong> the gene-specific primers allowing the HRM amplicons to be easily<br />
sequenced using a universal protocol in any high throughput sequencing<br />
setting.<br />
P11.061<br />
intra-intronic human minisatellite UPs29 associated with<br />
neurological diseases regulates reporter gene activity<br />
depending on its copy number in cell line F9<br />
L. Sasina 1 , I. Suchkova 1 , K. Solovyev 1 , N. Slominska 1 , V. S. Baranov 2 , E. Patkin<br />
1 ;<br />
1 Institute <strong>of</strong> Experimental Medicine, St.Petersburg, Russian Federation, 2 Ott’s<br />
Institute <strong>of</strong> Obstetrics & Gynecology, St.Petersburg, Russian Federation.<br />
Earlier we found the association <strong>of</strong> increased rate <strong>of</strong> short alleles <strong>of</strong><br />
minisatellite UPS29 localized in intron <strong>of</strong> CENTB5 gene with some<br />
forms <strong>of</strong> Parkinson disease and epilepsy. The molecular mechanism<br />
<strong>of</strong> such correlation remains mainly unclear. To elucidate this problem<br />
we generated PCR product corresponding to “healthy” (900bp) and<br />
to “disease” (400bp) UPS29 alleles. These PCR products were introduced<br />
into plasmid pEGFP with ROSA-betagco26 promoter and fused<br />
to reporter gene GFP. These plasmids were transfected into cells <strong>of</strong><br />
embryonal carcinoma line F9. Number <strong>of</strong> GFP-positive cells, their<br />
morphology and fluorescence intensity were analyzed with the help <strong>of</strong><br />
confocal microscopy after cultivation for 24 and 48h. Plasmids without<br />
UPS29 served as controls. There were no signal-positive cells in case<br />
<strong>of</strong> the same but minisatellite-free plasmids, though molecular analysis<br />
shower the presence <strong>of</strong> plasmids in F9 cells. Thus an GFP expression<br />
lacked in control, but appeared due to presence <strong>of</strong> UPS29 in construct.<br />
The number <strong>of</strong> GFP expressing cells depended on repeated<br />
units number in UPS29. The most high fluorescence was observed<br />
in neuron-like derivatives <strong>of</strong> F9 cells induced to differentiate. We suppose<br />
that such regularity could be explained by minisatellite-specific<br />
TF binding, and as a result UPS29 served as enhancer relatively to<br />
ROSA26 promoter. Obtained results point to possible mechanism <strong>of</strong><br />
regulatory function <strong>of</strong> intra-intronic and other non-protein coding repeats<br />
as additional enhancers. The shortening <strong>of</strong> one <strong>of</strong> minisatellite<br />
allele will lead to gene expression decrease and further to pathology.<br />
Acknowledgement. The work was supported by RFBR grant 08-04-<br />
12167<br />
P11.062<br />
Epigenetic study on regulation <strong>of</strong> normal and mutant kit gene in<br />
mice<br />
G. Cardos1 , A. Arghir1 , S. M. Chirieac1 , G. P. Savi1 , M. E. Hinescu1,2 ;<br />
1 2 ”Victor Babes” National Institute <strong>of</strong> Pathology, Bucharest, Romania, „Carol<br />
Davila” University <strong>of</strong> Medicine and Pharmacy, Bucharest, Romania.<br />
The Kit protein is a tyrosine-kinase receptor with a key-role in normal<br />
development <strong>of</strong> Interstitial Cajal Cells (ICC), the kit gene having different<br />
expression levels in various tissues and developmental stages.<br />
We report preliminary results <strong>of</strong> an epigenetic study on the kit gene<br />
regulation in order to find correlation (if any) between gene expression<br />
level and methylation status <strong>of</strong> its regulatory elements in mice, in different<br />
tissues and organs in which ICCs were identified.<br />
Different segments <strong>of</strong> gastrointestinal tract and extra-digestive organs<br />
were sampled from mutant B6Cg-KitW-sh /HnihrJaeBsmJ and control<br />
B6129PF2/J mice. RNA and DNA were extracted by DNA/RNA Mini Kit<br />
(Qiagen). Gene expression analysis was performed by Reverse Transcription-PCR<br />
methodology. The methylation status <strong>of</strong> the kit regulatory<br />
elements was studied by both enzymatic restrictions with methylation-sensitive<br />
BstUI endonuclease followed by PCR and Methylation<br />
Specific-PCR after bisulfitic treatment <strong>of</strong> DNA by EpiTect ® Bisulfit Kit<br />
(Qiagen).<br />
Our study revealed comparable levels <strong>of</strong> the kit gene expression in<br />
both mouse strains, high expression level being detected in bone marrow,<br />
spleen, liver and the lowest level in lung. Particular methylation<br />
pattern in a regulatory region (between -990 bp and -822 bp up-stream<br />
to the coding region) <strong>of</strong> the kit gene was identified in spleen, which<br />
may be correlated with high gene expression level. Our results suggest<br />
that DNA methylation may play an important role in tissue and<br />
organ-specific regulation <strong>of</strong> the kit gene, therefore our epigenetic study<br />
will be extended to other kit gene regulatory elements.<br />
Financial support: PN 06.26-02.18/2008 National Research Program.<br />
P11.063<br />
colocalisation <strong>of</strong> predicted exonic splicing enhancers in LAMA<br />
gene with reported sequence variants<br />
O. Siala, F. Fakhfakh;<br />
Laboratory <strong>of</strong> <strong>Human</strong> Molecular <strong>Genetics</strong>, SFAX, Tunisia.<br />
Translationally silent mutations were classified as polymorphisms.<br />
This assumption is now being challenged through the analysis <strong>of</strong> the<br />
mRNAs produced from mutant alleles, leading to the realization that<br />
a higher proportion <strong>of</strong> polymorphisms affect splicing. In our study, we<br />
analysed the colocalisation <strong>of</strong> exonic SNPs in LAMA2 gene related to<br />
the MDC1A form <strong>of</strong> congenital muscular dystrophy with exonic splicing<br />
enhancers (ESEs). Then, we searched the effect <strong>of</strong> allelic change on<br />
ESEs efficacy. The LAMA2 sequence was searched for ESE motifs<br />
using the web-based tool ESEfinder. Exons were screened for sequence<br />
motifs likely to be recognised by the SR proteins SF2/ASF,<br />
SC35, SRp40 and SRp55. Matching sequences are scored and only<br />
scores above thresholds are predicted to act as ESEs. Results showed<br />
the presence <strong>of</strong> 2709 ESEs in the 65 coding exons <strong>of</strong> LAMA2 gene;<br />
this number was reduced to 480 significant ESEs after applying the<br />
thresholds values filter. Secondly, the analysis <strong>of</strong> published sequence<br />
variations in LAMA2 gene showed the presence <strong>of</strong> 41 exonic SNPs, 18<br />
<strong>of</strong> them colocalize with the identified significant ESEs, representing a<br />
fraction <strong>of</strong> about 44%. In addition, the allelic changes in 5 synonymous<br />
or non synonymous SNPs can abolish or create an ESE suggesting<br />
their potentially functional role in LAMA2 gene expression. These results<br />
indicate the utility to consider the functional role <strong>of</strong> exonic SNPs<br />
in splicing and can also answer to many questions about the disease<br />
susceptibility and about the phenotypic variability observed in patients<br />
sharing with the same mutation in LAMA2 gene.<br />
P11.064<br />
the Utility <strong>of</strong> capillary Electrophoresis and Next Generation<br />
Sequencing platforms for scientific discovery<br />
B. Finkelnburg1 , F. Raffaldi2 , A. Ferlinz1 , J. Walker3 , P. Vatta3 , C. Cummings3 , A.<br />
Pradhan3 , M. Bozzini3 , A. Shah3 , A. Tam3 ;<br />
1 2 Applied Biosystems Deutschland GmbH, Darmstadt, Germany, Applera Italia,<br />
Monza, Italy, 3Applied Biosystems, Foster City, CA, United States.<br />
With its long read lengths and high accuracy, capillary electrophoresisbased<br />
sequencing is the gold standard technology for de novo projects.<br />
Typically in de novo projects for genetic analysis <strong>of</strong> any organism<br />
CE is considered ideal for creating high quality scaffolds. Now with the<br />
availability <strong>of</strong> sequencing by short-read next generation sequencing<br />
technologies system, this process is complemented through finishing<br />
with high coverage. Alternatively, short-read sequencing technologies<br />
<strong>of</strong>fer the throughput requirement for assaying large numbers <strong>of</strong> candidate<br />
regions or when resequencing pooled or heterogeneous samples.<br />
Next-generation sequencing is suited for large-scale discovery experiments,<br />
while CE with its high accuracy and unmatched data quality<br />
can be used to validate structural genetic variations<br />
We looked at de novo and targeted sequencing as two applications<br />
where each technology could be applied. In our analysis we consider<br />
sample preparation, and reagents, as well as key criteria that<br />
researchers consistently demand including accuracy, coverage, read<br />
length, quality values and ease <strong>of</strong> use.<br />
P11.065<br />
the Gen2Phen project: collecting gene sequence variants<br />
and their phenotypic consequences in web-based LsDBs for<br />
mendelian disorders<br />
I. F. A. C. Fokkema, P. E. M. Taschner, G. B. van Ommen, J. T. den Dunnen;<br />
Center for <strong>Human</strong> and Clinical <strong>Genetics</strong>, Leiden, The Netherlands.<br />
The EU-funded Gen2Phen project aims to provide a holistic view <strong>of</strong><br />
genotype-phenotype information. Gen2Phen facilitates the collection